SCM
Suvretta Capital Management Portfolio holdings
AUM
$2.65B
This Quarter Return
+5.52%
1 Year Return
+18.59%
3 Year Return
+180.23%
5 Year Return
+278.12%
10 Year Return
+1,101.07%
AUM
$2.07B
AUM Growth
+$2.07B
(-13%)
Cap. Flow
-$298M
Cap. Flow
% of AUM
-14.38%
Top 10 Holdings %
Top 10 Hldgs %
38.29%
Holding
115
New
23
Increased
36
Reduced
14
Closed
20
Top Buys
| 1 |
Elevance Health
ELV
|
$58.1M |
| 2 |
Amazon
AMZN
|
$57.8M |
| 3 |
Yum! Brands
YUM
|
$52.3M |
| 4 |
Royalty Pharma
RPRX
|
$38.6M |
| 5 |
89bio
ETNB
|
$33.7M |
Top Sells
| 1 |
Otis Worldwide
OTIS
|
$102M |
| 2 |
Tapestry
TPR
|
$83M |
| 3 |
Las Vegas Sands
LVS
|
$78.1M |
| 4 |
Union Pacific
UNP
|
$56.3M |
| 5 |
AT&T
T
|
$54.3M |
Sector Composition
| 1 | Healthcare | 54.01% |
| 2 | Consumer Discretionary | 14.68% |
| 3 | Technology | 7.64% |
| 4 | Communication Services | 6.4% |
| 5 | Consumer Staples | 5.35% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
1
Royalty Pharma
RPRX
$15.6B
| $110M | 4.64% | 3,047,049 +1,072,424 | +54% | +$38.6M |
|
|
HZNP
2
DELISTED
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
| $106M | 4.49% | 973,755 +99,464 | +11% | +$10.9M |
|
3
Kura Oncology
KURA
$686M
| $80.4M | 3.4% | 6,573,335 +196,520 | +3% | +$2.4M |
|
4
UnitedHealth
UNH
$281B
| $78.1M | 3.3% | 165,164 -91,550 | -36% | -$43.3M |
|
5
Meta Platforms (Facebook)
META
$1.86T
| $75.1M | 3.17% | 354,198 +107,939 | +44% | +$22.9M |
|
6
Arcellx
ACLX
$3.85B
| $73.9M | 3.12% | 2,398,321 +47,988 | +2% | +$1.48M |
|
7
Wynn Resorts
WYNN
$13.2B
| $72.7M | 3.07% | 649,761 -35,240 | -5% | -$3.94M |
|
|
8
Elevance Health
ELV
$71.8B
| $71.4M | 3.02% | 155,321 +126,350 | +436% | +$58.1M |
|
|
ITCI
9
DELISTED
Intra-Cellular Therapies Inc.
ITCI
| $64.9M | 2.74% | 1,198,971 +162,023 | +16% | +$8.77M |
|
10
Advanced Micro Devices
AMD
$264B
| $61.1M | 2.58% | 622,916 +139,160 | +29% | +$13.6M |
|
11
Hilton Worldwide
HLT
$64.9B
| $59.5M | 2.51% | 422,094 -14,662 | -3% | -$2.07M |
|
|
12
Amazon
AMZN
$2.44T
| $57.8M | 2.44% | +559,490 | New | +$57.8M |
|
13
Estee Lauder
EL
$33B
| $56.4M | 2.38% | 228,806 -169,700 | -43% | -$41.8M |
|
14
Constellation Energy
CEG
$96.2B
| $55.2M | 2.33% | 702,609 +270,640 | +63% | +$21.2M |
|
15
Colgate-Palmolive
CL
$67.9B
| $54.4M | 2.3% | 724,140 +79,560 | +12% | +$5.98M |
|
16
Biohaven
BHVN
$1.63B
| $52.6M | 2.22% | 3,848,938 | – | – |
|
|
17
Yum! Brands
YUM
$40.8B
| $52.3M | 2.21% | +396,050 | New | +$52.3M |
|
18
Insmed
INSM
$28.8B
| $50M | 2.11% | 2,932,138 +411,237 | +16% | +$7.01M |
|
|
19
Union Pacific
UNP
$133B
| $48.6M | 2.05% | 241,581 -279,592 | -54% | -$56.3M |
|
20
Terns Pharmaceuticals
TERN
$609M
| $40.8M | 1.72% | 3,448,275 | – | – |
|
21
Canadian Pacific Kansas City
CP
$69.9B
| $38.4M | 1.62% | 498,810 -267,030 | -35% | -$20.5M |
|
22
Nike
NKE
$114B
| $37.7M | 1.59% | 307,637 -190,300 | -38% | -$23.3M |
|
|
KDNY
23
DELISTED
Chinook Therapeutics, Inc. Common Stock
KDNY
| $36.3M | 1.53% | 1,568,797 +123,967 | +9% | +$2.87M |
|
24
ProKidney
PROK
$319M
| $36.1M | 1.53% | 3,193,175 | – | – |
|
25
Oracle
ORCL
$635B
| $34.1M | 1.44% | 366,513 +8,200 | +2% | +$762K |
|